What is the ideal time to perform an external cephalic version (ECV) on a multigravida (a woman who has been pregnant more than once) at 32 weeks of gestation with a fetus in breech presentation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Optimal Timing for External Cephalic Version

The ideal time to perform external cephalic version (ECV) for this multigravida at 32 weeks with breech presentation is at 37 weeks (Option C).

Evidence-Based Timing Recommendations

ECV should be performed starting at 36-37 weeks' gestation, not earlier. 1 The French College of Obstetricians and Gynecologists (CNGOF) specifically recommends that ECV attempts should be performed from 36 weeks onward, balancing efficacy with safety. 1

Why Not Earlier (34 weeks)?

While early ECV (34-35 weeks) does reduce non-cephalic presentation at birth compared to ECV at 37-38 weeks, it comes with a significant trade-off:

  • Early ECV increases the risk of late preterm birth (RR 1.51,95% CI 1.03-2.21), with preterm labor rates of 6.6% in the early ECV group versus 4.3% in the term ECV group. 2
  • The rate of spontaneous version to cephalic before term is substantial, meaning many early ECVs may be unnecessary. 2
  • Although early ECV reduces non-cephalic presentation at birth (RR 0.81,95% CI 0.74-0.90), the increased prematurity risk outweighs this benefit when considering neonatal morbidity and mortality. 2

Why 37 Weeks is Optimal

At 37 weeks' gestation, ECV achieves the best balance of success rate and safety:

  • Success rates are highest at 37 weeks (81.25% successful versions with 76.9% subsequent vaginal deliveries). 3
  • There is immediate access to emergency cesarean section if complications arise, without the added risks of prematurity. 1
  • The fetus has reached early term, minimizing neonatal complications if emergency delivery becomes necessary. 3

Why Not Later (39 weeks or in labor)?

  • ECV in labor (Option A) is contraindicated - the procedure requires controlled conditions with immediate access to emergency cesarean section, which is incompatible with active labor management. 1
  • Delaying until 39 weeks (Option B) reduces success rates as the fetus becomes larger and amniotic fluid volume decreases, making version technically more difficult. 3

Essential Safety Protocols

When performing ECV at 37 weeks, the following must be in place:

  • Immediate access to an operating room for emergency cesarean section. 1
  • Parenteral tocolysis (β-mimetic or atosiban) should be used to increase success rates (from approximately 60% to 80%). 1
  • Cardiotocography should be performed before and for 30 minutes after the procedure to monitor for transient fetal heart rate abnormalities. 1
  • RH-1 prophylaxis for Rh-negative women (though routine Kleihauer testing is not necessary as significant fetomaternal hemorrhage risk is <0.1%). 1

Favorable Prognostic Factors for This Patient

As a multigravida, this patient has excellent prognostic factors:

  • Multiparity is the strongest predictor of ECV success. 4, 2
  • Success rates in multiparous women can reach 80% or higher. 4
  • The absence of maternal obesity further improves success rates. 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.